Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -85,024 | -58,390 | -37,346 | -18,417 | -67,828 |
| Depreciation Amortization | -40 | -17 | 18 | 9 | 155 |
| Other Working Capital | -1,152 | -4,063 | -3,365 | -906 | 9,361 |
| Other Operating Activity | 14,035 | 8,729 | 5,641 | 2,229 | 8,693 |
| Operating Cash Flow | $-72,182 | $-53,741 | $-35,051 | $-17,085 | $-49,619 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,910 | -57,750 | -54,274 | -44,689 | -4,308 |
| PPE Investments | -113 | -94 | N/A | N/A | -129 |
| Sale Of Investment | N/A | 52,388 | 35,468 | 15,067 | N/A |
| Investing Cash Flow | $10,797 | $-5,457 | $-18,806 | $-29,622 | $-4,437 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5 | -3 | N/A | N/A | N/A |
| Common Stock Issued | 66,039 | 66,083 | 65,972 | 57,143 | 48,535 |
| Financing Cash Flow | $66,034 | $66,080 | $65,972 | $57,143 | $48,535 |
| Beginning Cash Position | 4,795 | 4,795 | 4,795 | 4,795 | 10,316 |
| End Cash Position | 9,444 | 11,678 | 16,909 | 15,231 | 4,795 |
| Net Cash Flow | $4,649 | $6,883 | $12,114 | $10,436 | $-5,521 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,182 | -53,741 | -35,051 | -17,085 | -49,619 |
| Capital Expenditure | -113 | -94 | N/A | N/A | -129 |
| Free Cash Flow | -72,295 | -53,835 | -35,051 | -17,085 | -49,748 |